CIK 0001788028
- Non-accelerated filer
- Smaller reporting company
Jasper Therapeutics, Inc.
Sign in to watch- Ticker
- JSPR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 842984849
- Phone
- +1 650-549-1400
- Business address
- 2200 BRIDGE PKWY SUITE #102, REDWOOD CITY, CA, 94065
- Former names
- Amplitude Healthcare Acquisition Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-31 | WIGGANS THOMAS G Director | Grant or award · Stock Option (Right to Buy | +7,500 | 7,500 | ||
| 2025-09-22 | WIGGANS THOMAS G Director | Purchase | +41,000 | $2.43 | $100K | 41,000 |
| 2025-09-22 | WIGGANS THOMAS G Director | Purchase · Common Stock Warrant (right to buy) | +41,000 | 41,000 | ||
| 2025-07-03 | WIGGANS THOMAS G Director | Grant or award · Stock Option (right to buy) | +7,500 | 7,500 | ||
| 2024-06-06 | WIGGANS THOMAS G Director | Grant or award · Stock Option (right to buy) | +7,500 | 7,500 | ||
| 2023-11-28 | WIGGANS THOMAS G Director | Purchase | +10,000 | $0.65 | $6K | 50,000 |
| 2023-11-21 | WIGGANS THOMAS G Director | Purchase | +10,000 | $0.64 | $6K | 40,000 |
| 2023-11-20 | WIGGANS THOMAS G Director | Purchase | +10,000 | $0.63 | $6K | 30,000 |
| 2023-11-17 | WIGGANS THOMAS G Director | Purchase | +10,000 | $0.60 | $6K | 20,000 |
| 2023-11-16 | WIGGANS THOMAS G Director | Purchase | +10,000 | $0.60 | $6K | 10,000 |
| 2023-11-01 | WIGGANS THOMAS G Director | Grant or award · Stock Option (right to buy) | +110,000 | 110,000 |
Page 1 of 1 · 11 trades